Alain Kentos

3PUBLICATIONS
12CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Aug 22, 2025
Frail subgroups determine heterogeneous outcomes in older patients with NDMM: long-term follow-up of the HOVON 143 trial.

Febe Smits, Kaz Groen, Mark-David Levin

|Nov 22, 2024
Beyond static measurements: dynamic frailty improves survival prediction in multiple myeloma.

Febe Smits, Kaz Groen, Mark-David Levin

|May 04, 2021
Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma: The Hovon 143 Study.

Claudia A M Stege, Kazem Nasserinejad, Ellen van der Spek

Pageof 1

Frequent Collaborators

3 joint publications

Nicole C H P de Graauw

3 joint publications

Mark-David Levin

3 joint publications

Sonja Zweegman

2 joint publications

Maarten R Seefat

2 joint publications

Yorick Sandberg

1 joint publications

Claudia A M Stege

1 joint publications

Kazem Nasserinejad

1 joint publications

Marie-Christiane Vekemans

1 joint publications

Marjolein van der Klift

1 joint publications

Paul A F Geerts

Frequent Collaborators

3 joint publications

Nicole C H P de Graauw

3 joint publications

Mark-David Levin

3 joint publications

Sonja Zweegman

2 joint publications

Maarten R Seefat

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
05:53

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty

Published on : Jul 24, 2013

16.7K
Identifying Frailty Using Point-of-Care Ultrasonography: Image Acquisition and Assessment
04:00

Identifying Frailty Using Point-of-Care Ultrasonography: Image Acquisition and Assessment

Published on : Jul 26, 2024

459
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on : May 15, 2019

13.5K
See more related videos

Top Related Videos

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
05:53

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty

Published on : Jul 24, 2013

16.7K
Identifying Frailty Using Point-of-Care Ultrasonography: Image Acquisition and Assessment
04:00

Identifying Frailty Using Point-of-Care Ultrasonography: Image Acquisition and Assessment

Published on : Jul 26, 2024

459
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on : May 15, 2019

13.5K
See more related videos